{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:14:26Z","timestamp":1761948866112,"version":"build-2065373602"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","oooojournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.oooo.2020.06.011","type":"journal-article","created":{"date-parts":[[2020,6,20]],"date-time":"2020-06-20T13:54:06Z","timestamp":1592661246000},"page":"e9-e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6042-361X","authenticated-orcid":false,"given":"Heba","family":"Hussein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.oooo.2020.06.011_bib0001","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s40261-018-0656-y","article-title":"Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic, and neurological diseases: a mini-review","volume":"38","author":"Plantone","year":"2018","journal-title":"Clin Drug Investig"},{"issue":"6","key":"10.1016\/j.oooo.2020.06.011_bib0002","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.oooo.2020.03.047","article-title":"Hydroxychloroquine and \u201coff-label\u201d utilization in the treatment of oral conditions","volume":"129","author":"Brown","year":"2020","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0003","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.tripleo.2007.02.013","article-title":"Chronic ulcerative stomatitis: diagnostic and management challenges\u2014four new cases and review literature","volume":"104","author":"Islam","year":"2007","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.06.011_bib0004","first-page":"119","article-title":"Chronic ulcerative stomatitis: a distinct clinical entity","volume":"66","author":"Fourie","year":"2011","journal-title":"SADJ"},{"key":"10.1016\/j.oooo.2020.06.011_bib0005","doi-asserted-by":"crossref","first-page":"e109","DOI":"10.1111\/ajd.12948","article-title":"Hydroxychloroquine sulphate therapy of erosive oral lichen planus","volume":"60","author":"Yeshurun","year":"2019","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0006","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.tripleo.2010.02.032","article-title":"Effects of hydroxychloroquine on salivary flow rates and oral complaints of Sjogren patients: a prospective sample study","volume":"110","author":"Cankaya","year":"2010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.06.011_bib0007","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.rdc.2016.03.010","article-title":"New Treatment guidelines for Sjogren's disease","volume":"42","author":"Vivino","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.oooo.2020.06.011_bib0008","first-page":"111","article-title":"Sweet's syndrome following therapy with hydroxychloroquine in a patient with primary Sjogren's syndrome","volume":"6","author":"Manzo","year":"2019","journal-title":"Medicines (Basel)"},{"key":"10.1016\/j.oooo.2020.06.011_bib0009","article-title":"FDA approves hydroxychloroquine new drug application to address COVID-19 related shortage","author":"Kim","year":"2020","journal-title":"FDA News"},{"key":"10.1016\/j.oooo.2020.06.011_bib0010","doi-asserted-by":"crossref","unstructured":"Mehra MR, Desai SS, Fuschitzka F, Patel AN. Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis. Lancet. doi:10.1016\/S0140-6736(20)31180-6, accessed June 25, 2020. (retracteded on June 25, 2020).","DOI":"10.1016\/S0140-6736(20)31180-6"},{"key":"10.1016\/j.oooo.2020.06.011_bib0011","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.oooo.2020.06.011_bib0012","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.oooo.2020.06.011_bib0013","article-title":"Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine","volume":"2016","author":"O'Laughlin","year":"2016","journal-title":"Case Rep Cardiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","article-title":"Development and validation of a risk score to predict QT interval prolongation in hospitalized patients","volume":"6","author":"Tisdale","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.oooo.2020.06.011_bib0015","article-title":"Hydroxychloroquine: Turkey insists on using drug despite WHO concerns","author":"Soylu","year":"2020","journal-title":"Middle East Eye"},{"key":"10.1016\/j.oooo.2020.06.011_bib0016","first-page":"545","article-title":"Electrocardiograph abnormalities related to anti-malarials in systemic lupus erythematosus","volume":"36","author":"McGhie","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0017","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002867","article-title":"Hydroxychloroquine use is associated with decreased incident cardiovascular events in rheumatoid arthritis patients","volume":"5","author":"Sharma","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.oooo.2020.06.011_bib0018","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2344\/0003-3006-56.2.42","article-title":"Review and management of dental patient with long QT syndrome (LQTS)","volume":"56","author":"Rochford","year":"2009","journal-title":"Anes Prog"},{"year":"2017","series-title":"Clinician's Guide to Treatment of Common Oral Conditions","key":"10.1016\/j.oooo.2020.06.011_bib0019"},{"key":"10.1016\/j.oooo.2020.06.011_bib0020","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1468-3083.2006.01832.x","article-title":"Successful treatment of oral erosive lichen planus with mycophenolate mofetil","volume":"21","author":"Dalmau","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0021","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cden.2018.06.002","article-title":"Painful oral lesions","volume":"62","author":"Hargitai","year":"2018","journal-title":"Dent Clin North Am"},{"key":"10.1016\/j.oooo.2020.06.011_bib0022","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/bjd.17898","article-title":"Topical calcineurin inhibitors in the treatment of oral lichen planus: a systematic review and meta-analysis","volume":"181","author":"Sun","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0023","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.medcli.2017.06.024","article-title":"Treatment of oral lichen planus. Systematic review and therapeutic guide","volume":"149","author":"Garc\u00eda-Pola","year":"2017","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.oooo.2020.06.011_bib0024","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1517\/14728214.2011.528390","article-title":"Topical immunomodulators for management of oral mucosal conditions, a systematic review. Part II: Miscellaneous agents","volume":"16","author":"Elad","year":"2011","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.oooo.2020.06.011_bib0025","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/odi.12634","article-title":"Interventions for the management of oral lichen planus: a review of the conventional and novel therapies","volume":"23","author":"Gupta","year":"2017","journal-title":"Oral Dis"},{"key":"10.1016\/j.oooo.2020.06.011_bib0026","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.oooo.2019.07.024","article-title":"Intralesional triamcinolone acetonide therapy for inflammatory oral ulcers","volume":"128","author":"Fantozzi","year":"2019","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0027","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.oooo.2013.07.023","article-title":"Efficacy of intralesional betamethasone for erosive oral lichen planus and evaluation of recurrence: a randomized, controlled trial","volume":"116","author":"Liu","year":"2013","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0028","first-page":"116","article-title":"Dental drug interactions with the greatest potential for serious adverse effects","volume":"42","author":"Wynn","year":"1994","journal-title":"Gen Dent"},{"key":"10.1016\/j.oooo.2020.06.011_bib0029","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev.pa.36.040196.001313","article-title":"Cardiac actions of antihistamines","volume":"36","author":"Woosley","year":"1996","journal-title":"Annu Rev Pharacol Toxicol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0030","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1136\/bmj.319.7201.7a","article-title":"Antihistamine drug withdrawn by manufacturer","volume":"319","author":"Gottlieb","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.oooo.2020.06.011_bib0031","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2174\/157340309788970397","article-title":"Iatrogenic QT abnormalities and fatal arrhythmias: mechanisms and clinical significance","volume":"5","author":"Cubeddu","year":"2009","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.oooo.2020.06.011_bib0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1573403X12666160301120217","article-title":"Drug-induced inhibition and trafficking disruption of ion channels: pathogenesis of QT abnormalities and drug-induced fatal arrhythmias","volume":"12","author":"Cubeddu","year":"2016","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.oooo.2020.06.011_bib0033","article-title":"Azithromycin causes a novel proarrhythmic syndrome","volume":"10","author":"Yan","year":"2017","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0034","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1574806","article-title":"Risk evaluation of azithromycin-induced QT prolongation in real-world practice","volume":"2018","author":"Choi","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.oooo.2020.06.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1177\/1060028013504905","article-title":"Azithromycin-induced proarrhythmia and cardiovascular death","volume":"47","author":"Howard","year":"2013","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.oooo.2020.06.011_bib0036","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1345\/aph.17299","article-title":"Pharmacokinetics and pharmacodynamics of intravenous and oral azithromycin: enhanced tissue activity and minimal drug interactions","volume":"32","author":"Rapp","year":"1998","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.oooo.2020.06.011_bib0037","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/ejhpharm-2016-001077","article-title":"QTc prolongation during erythromycin used as prokinetic agent in ICU patients","volume":"25","author":"Fiets","year":"2018","journal-title":"Eur J Hosp Pharm"},{"key":"10.1016\/j.oooo.2020.06.011_bib0038","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jwh.1998.7.547","article-title":"Female gender as a risk factor for drug-induced cardiac arrhythmias: evaluation of clinical and experimental evidence","volume":"5","author":"Ebert","year":"1998","journal-title":"J Womens Health"},{"key":"10.1016\/j.oooo.2020.06.011_bib0039","doi-asserted-by":"crossref","first-page":"575","DOI":"10.2165\/00002018-200124080-00002","article-title":"Is gender a risk factor for adverse drug reactions? The example of drug-induced long QT syndrome","volume":"24","author":"Drici","year":"2001","journal-title":"Drug Saf"},{"key":"10.1016\/j.oooo.2020.06.011_bib0040","doi-asserted-by":"crossref","first-page":"5257","DOI":"10.1111\/j.1540-8167.2005.40845.x","article-title":"Gender-related differences in ventricular repolarization: beyond gonadal steroids","volume":"16","author":"Arya","year":"2005","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0041","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2125.1988.tb05281.x","article-title":"A dose-ranging study of the pharmacokinetics of hydroxychloroquine following intravenous administration to healthy volunteers","volume":"26","author":"Tett","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0042","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S0022-3565(25)27280-9","article-title":"Studies of the metabolism of some compounds of the 4-amino-7-chloroquinoline series","volume":"151","author":"McChesney","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.oooo.2020.06.011_bib0043","doi-asserted-by":"crossref","first-page":"630","DOI":"10.14219\/jada.archive.2006.0259","article-title":"Dental treatment of patients with long QT syndrome","volume":"137","author":"Karp","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2020.06.011_bib0044","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0025-6196(11)62209-X","article-title":"Epinephrine-induced QT interval prolongation: a gene specific paradoxical response in congenital long QT syndrome","volume":"77","author":"Ackerman","year":"2002","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.oooo.2020.06.011_bib0045","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.14219\/jada.archive.2006.0338","article-title":"Long QT syndrome","volume":"137","author":"Brown","year":"2006","journal-title":"J Am Dent Assoc"},{"key":"10.1016\/j.oooo.2020.06.011_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/S1079-2104(03)00380-9","article-title":"Dental management of the patients with cardiac arrhythmias: an update","volume":"96","author":"Rhodus","year":"2003","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.06.011_bib0047","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.tripleo.2005.05.074","article-title":"Epinephrine and local anesthesia revisited","volume":"100","author":"Brown","year":"2005","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol Endod"},{"key":"10.1016\/j.oooo.2020.06.011_bib0048","first-page":"25","article-title":"The chicken little syndrome","volume":"73","author":"Brown","year":"2006","journal-title":"J Am Coll Dent"},{"key":"10.1016\/j.oooo.2020.06.011_bib0049","first-page":"176","article-title":"Articaine 4% with 1:200,000 epinephrine: an acceptable option for patients with long QT syndrome","volume":"55","author":"Wynn","year":"2007","journal-title":"Gen Dent"},{"key":"10.1016\/j.oooo.2020.06.011_bib0050","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2215\/CJN.12991216","article-title":"Association of QT prolonging medication use in CKD with electrocardiographic manifestations","volume":"12","author":"Snitker","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0051","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","article-title":"Hydroxychloroquine: from malaria to autoimmunity","volume":"42","author":"Ben-Zvi","year":"2012","journal-title":"Clin Rev Allerg Immunol"},{"key":"10.1016\/j.oooo.2020.06.011_bib0052","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/0961203309360539","article-title":"Ocular side effects of anti-rheumatic medications: what a rheumatologist should know","volume":"19","author":"Peponis","year":"2010","journal-title":"Lupus"},{"key":"10.1016\/j.oooo.2020.06.011_bib0053","doi-asserted-by":"crossref","first-page":"919","DOI":"10.4103\/njcp.njcp_380_16","article-title":"What is new in recommendations on ophthalmological screening in patients treated with chloroquine and hydroxychloroquine? Update and literature review","volume":"20","author":"Wiacek","year":"2017","journal-title":"Niger J Clin Pract"},{"key":"10.1016\/j.oooo.2020.06.011_bib0054","first-page":"343","article-title":"Medical consultations for medically complex dental patients","volume":"35","author":"Brown","year":"2007","journal-title":"J Calif Dent Assoc"}],"container-title":["Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320310701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212440320310701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T22:07:56Z","timestamp":1761948476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212440320310701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2212440320310701"],"URL":"https:\/\/doi.org\/10.1016\/j.oooo.2020.06.011","relation":{},"ISSN":["2212-4403"],"issn-type":[{"type":"print","value":"2212-4403"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydroxychloroquine and the treatment of Sjogren syndrome, chronic ulcerative stomatitis, and oral lichen planus in the age of COVID-19","name":"articletitle","label":"Article Title"},{"value":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.oooo.2020.06.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}